Autoradiographic distribution of μ, δ and κ opioid binding sites in the superficial dorsal horn, over the rostrocaudal axis of the rat spinal cord

doi:10.1016/0006-8993(91)91134-M

Brain Research

Volume 548, Issues 1–2, 10 May 1991, Pages 287-291

https://doi.org/10.1016/0006-8993(91)91134-M Get rights and content

Abstract

The purpose of this study was to use [³H]DAMGO, [³H]DTLET and [³H]EKC in the presence of 100 nM DAMGO and 100 nM DTLET, combined with a quantitative autoradiography to analyse the different proportions and the rostrocaudal distribution of μ, δ and κ opioid binding sites in the superficial layers (laminae I and II) of the cervical (C₆–C₈), thoracic (T₅–T₇), lumbar (L₃–L₅) and sacral (S₂–S₃) dorsal horn of the rat. The proportions of the three main types of opioid binding sites, assessed by autoradiography in laminae I and II, were found homogeneous at each segmental level considered: 70.4–74.3%, 18.4–20.3% and 7.3–9.5% for μ, δ, κ sites, respectively. The physiological relevance of these data is discussed.

References (18)

BesseD. et al.
Pre- and postsynaptic distribution of μ, δ and κ opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord
Brain Research
(1990)
CzlonkowskiA. et al.
Opiate receptor binding sites in human spinal cord
Brain Research
(1983)
Delay-GoyetP. et al.
Differences of binding characteristics of non-selective opiates towards μ and δ receptors types
Life Sci.
(1987)
DickensonA.H. et al.
Opioid receptor subtypes in the rat spinal cord: electrophysiological studies with μ and δ opioid receptor agonists in the control of nociception
Brain Research
(1987)
GouardèresC. et al.
Opioid binding sites in different levels of rat spinal cord
Neuropeptides
(1984)
GouardèresC. et al.
Autoradiographic localization of mu, delta and kappa opioid receptor binding sites in rat and guinea pig spinal cord
Neuropeptides
(1985)
KnoxR.J. et al.
Effects of selective and non-selective κ opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones
Brain Research
(1987)
NagyJ.I. et al.
Neurotoxic action of capsaicin on spinal substance P neurons
Brain Research
(1980)
TraynorJ.R. et al.
Distribution of opioid binding sites in spinal cord
Neuropeptides
(1987)

There are more references available in the full text version of this article.

Cited by (92)

Intrathecal fentanyl blockade of afferent neural feedback from skeletal muscle during exercise in heart failure patients: Influence on circulatory power and pulmonary vascular capacitance
2015, International Journal of Cardiology
Citation Excerpt :
Assessment of the influence of feedback from group III/IV nerve fibers during exercise in humans remains challenging. However, μ-opioid receptors which can be found superficially located on the lumbar dorsal horn of the spinal cord where group III/IV nerve fibers synapse represent a feasible target for pharmacological manipulation of afferent neural signaling [21–24]. The selective μ-opioid receptor agonist has been shown to inhibit the cortical projection of group III/IV neural feedback in human and animal models [16,21,25].
Secondary pulmonary hypertension is common in heart failure (HF) patients. We hypothesized that inhibition of feedback from locomotor muscle group III/IV neurons contributes to reduced pulmonary vascular pressures independent of changes in cardiac function during exercise in HF.
9 HF patients (ages, 60 ± 2; EF, 26.7 ± 1.9%; New York Heart Association classes, I–III) and 9 age/gender matched controls (ages, 63 ± 2) completed five-minutes of constant-load cycling (65% Workload_peak) with intrathecal fentanyl or placebo on randomized separate days. Mean arterial pressure (MAP), heart rate (HR), end-tidal partial pressure of CO₂ (P_ETCO₂), and oxygen consumption (VO₂) were measured at rest and exercise. Non-invasive surrogates for cardiac power (circulatory power, CircP = VO₂ × MAP), stroke volume (oxygen pulse, O₂pulse = VO₂/HR), and pulmonary arterial pressure (GX_CAP = O₂pulse × P_ETCO₂) were calculated.
At rest and end-exercise, differences between fentanyl versus placebo were not significant for CircP in HF or controls. Differences between fentanyl versus placebo for GX_CAP were not significant at rest in HF or controls. At end-exercise, GX_CAP was significantly higher with fentanyl versus placebo in HF (691 ± 59 versus 549 ± 38 mL/beat × mm Hg), but not controls (536 ± 59 versus 474 ± 43 mL/beat × mm Hg). Slopes (rest to end-exercise) for GX_CAP were significantly higher with fentanyl versus placebo in HF (95.1 ± 9.8 versus 71.6 ± 6.0 mL/beat × mm Hg), but not controls (74.3 ± 9.5 versus 60.8 ± 6.5 mL/beat × mm Hg). CircP slopes did not differ between fentanyl versus placebo in HF or controls (p > 0.05).
We conclude that feedback from locomotor muscle group III/IV neurons may evoke increases in pulmonary vascular pressures independent of changes in cardiac function during exercise in HF.
Opioid administration following spinal cord injury: Implications for pain and locomotor recovery
2013, Experimental Neurology
Citation Excerpt :
How locomotor function and pain are affected by opioids following SCI, however, has yet to be fully examined. Three classic opioid receptors, the μ-opioid receptor (MOR), δ-opioid receptor (DOR), and κ-opioid receptor (KOR) have been identified and are located throughout regions of the brain, brainstem, spinal cord, and periphery on both presynaptic (e.g. afferent fibers), postsynaptic (e.g. dorsal horn neurons), and glial cells (Arvidsson et al., 1995; Atweh and Kuhar, 1977a, 1977b, 1977c; Besse et al., 1990a, 1990b, 1991; Fields et al., 1980; Mansour et al., 1987; Pert and Snyder, 1973a, 1973b; Pert et al., 1973; Simon, 1973; Terenius, 1973; Yaksh, 1997; reviewed by Hutchinson et al., 2011; Stein et al., 1989; Yaksh and Noueihed, 1985). Traditionally, opioid receptor agonists are known for their analgesic (antinociceptive) and rewarding, hedonic properties.
Approximately one-third of people with a spinal cord injury (SCI) will experience persistent neuropathic pain following injury. This pain negatively affects quality of life and is difficult to treat. Opioids are among the most effective drug treatments, and are commonly prescribed, but experimental evidence suggests that opioid treatment in the acute phase of injury can attenuate recovery of locomotor function. In fact, spinal cord injury and opioid administration share several common features (e.g. central sensitization, excitotoxicity, aberrant glial activation) that have been linked to impaired recovery of function, as well as the development of pain. Despite these effects, the interactions between opioid use and spinal cord injury have not been fully explored. A review of the literature, described here, suggests that caution is warranted when administering opioids after SCI. Opioid administration may synergistically contribute to the pathology of SCI to increase the development of pain, decrease locomotor recovery, and leave individuals at risk for infection. Considering these negative implications, it is important that guidelines are established for the use of opioids following spinal cord and other central nervous system injuries.
Opioid-mediated regulation of A11 diencephalospinal dopamine neurons: Pharmacological evidence of activation by morphine
2011, Neuropharmacology
Dopamine (DA) neurons of the A11 diencephalospinal system represent the sole source of DA innervation to the spinal cord in mice, serving neuromodulatory roles in the processing of nociceptive input and movement. These neurons originate in the dorso-caudal diencephalon and project axons unilaterally throughout the rostrocaudal extent of the spinal cord, terminating predominantly in the dorsal horn. The density of A11 DA axon terminals in the lumbar region is greater in males compared to females, while in both sexes the activity of neurons terminating in the thoracic spinal cord is greater than those terminating in the lumbar region. The present study was designed to test the hypothesis that A11 DA neurons are activated by opioids. To test this hypothesis, male and female mice were systemically treated with agonists or antagonists acting at the μ-opioid receptor, and spinal cord concentrations of DA and its metabolite DOPAC were determined in the thoracic and lumbar spinal cord using high performance liquid chromatography coupled with electrochemical detection. Systemic administration of the μ-opioid agonist morphine led to a dose- and time-dependent increase in spinal cord DOPAC/DA ratio (an estimate of DA neuronal activity) in both male and female mice, with greater changes occurring in the lumbar segment. Blockade of opioid receptors with the opioid antagonist naloxone reversed the stimulatory effects of morphine on A11 DA neurons in both male and female mice, but had little to no effect on the activity of these neurons when administered alone. Present findings are consistent with the conclusion that spinal cord-projecting axon terminals of A11 DA neurons are activated by opioids in both male and female mice, most likely through a dis-inhibitory mechanism.
Spinal motor actions of the μ-opioid receptor agonist DAMGO in the cat
2011, Neuroscience Research
For further evaluation of opioidergic spinal motor functions the action of the μ-opioid receptor agonist DAMGO was tested on transmission in different non-nociceptive and nociceptive spinal reflex pathways from flexor reflex afferents (FRA), and in non-FRA reflex pathways in spinal cats. The action of DAMGO was complex, not following a simple pattern with selective depression of nociceptive pathways compared to non-nociceptive ones. Monosynaptic reflexes of the flexor posterior biceps semitendinosus (PBSt) and transmission in nociceptive as well as non-nociceptive excitatory FRA pathways to PBSt were depressed, while the specific excitatory nociceptive non-FRA pathway from the central foot pad to foot extensors was mainly not depressed but rather facilitated by DAMGO. DAMGO caused a facilitation of monosynaptic reflexes to the extensor gastrocnemius soleus (GS) and partly a reversal of inhibitory to excitatory conditioning effects from cutaneous afferents to GS. FRA interneurones could show either an increase or a cessation of their spontaneous activity, but responsiveness to nociceptive and non-nociceptive afferent activation was blocked by DAMGO. The main DAMGO action is generated via interneuronal systems rather than on motoneurones themselves. The results indicate that opioidergic spinal functions are extensively involved in spinal motor control exceeding a mere suppression of nociceptive motor withdrawal reactions.
Sorting of neuropeptides and neuropeptide receptors into secretory pathways
2010, Progress in Neurobiology
There are two major secretory pathways in neurons, the regulated pathway and the constitutive pathway. Neuropeptides and other regulated secretory proteins are known to be sorted into large dense-core vesicles of the regulated pathway in the trans-Golgi network and are secreted upon stimulus-induced increases in intracellular Ca²⁺. The newly synthesized cell surface receptors are usually sorted into microvesicles of the constitutive pathway and inserted into the plasma membrane by spontaneous exocytosis. Small-diameter sensory neurons in dorsal root ganglia and pheochromocytoma cells express neuropeptides (e.g., substance P) and several neuropeptide receptors including opioid receptors. The μ-opioid receptors are delivered to the cell surface through the constitutive pathway, whereas another type of opioid receptor, the δ-opioid receptor, is often found in the membrane of large dense-core vesicles and can be inserted into the plasma membrane when exocytosis occurs. Recent studies show that sequences with opposite electrical polarity within the prohormones of substance P are essential for their sorting into large dense-core vesicles. Moreover, the δ-opioid receptor is sorted into large dense-core vesicles by its interaction with protachykinin, a prohormone of substance P. These findings provide insight into the molecular mechanisms that determine the sorting and trafficking of neuropeptides and neuropeptide receptors in neurons.
Characteristics and comparative severity of respiratory response to toxic doses of fentanyl, methadone, morphine, and buprenorphine in rats
2009, Toxicology Letters
Opioids are known to induce respiratory depression. We aimed to characterize in rats the effects of four opioids on arterial blood gases and plethysmography after intraperitoneal administration at 80% of their LD₅₀ in order to identify opioid molecule-specific patterns and classify response severity. Opioid-receptor (OR) antagonists, including intravenous 10 mg kg⁻¹-naloxonazine at 5 min [mu-OR antagonist], subcutaneous 30 mg kg⁻¹-naloxonazine at 24 h [mu1-OR antagonist], subcutaneous 3 mg kg⁻¹-naltrindole at 45 min [delta-OR antagonist], and subcutaneous 5 mg kg⁻¹-Nor-binaltorphimine at 6 h [kappa-OR antagonist] were pre-administered to test the role of each OR. Methadone, morphine, and fentanyl significantly decreased PaO₂ (P < 0.001) and increased PaCO₂ (P < 0.05), while buprenorphine only decreased PaO₂ (P < 0.05). While all opioids significantly increased inspiratory time (T_I, P < 0.001), methadone and fentanyl also increased expiratory time (T_E, P < 0.05). Intravenous 10 mg kg⁻¹-naloxonazine at 5 min completely reversed opioid-related effects on PaO₂ (P < 0.05), PaCO₂ (P < 0.001), T_I (P < 0.05), and T_E (P < 0.01) except in buprenorphine. Subcutaneous 30 mg kg⁻¹-naloxonazine at 24 h completely reversed effects on PaCO₂ (P < 0.01) and T_E (P < 0.001), partially reversed effects on T_I (P < 0.001), and did not reverse effects on PaO₂. Naltrindole reversed methadone-induced T_E increases (P < 0.01) but worsened fentanyl's effect on PaCO₂ (P < 0.05) and T_I (P < 0.05). Nor-binaltorphimine reversed morphine- and buprenorphine-induced T_I increases (P < 0.001) but worsened methadone's effect on PaO₂ (P < 0.05) and morphine (P < 0.001) and buprenorphine's (P < 0.01) effects on pH. In conclusion, opioid-related respiratory patterns are not uniform. Opioid-induced hypoxemia as well as increases in T_I and T_E are caused by mu-OR, while delta and kappa-OR roles appear limited, depending on the specific opioid. Regarding severity of opioid-induced respiratory effects at 80% of their LD₅₀, all drugs increased T_I. Methadone and fentanyl induced hypoxemia, hypercapnia, and T_E increases, morphine caused both hypoxemia and hypercapnia while buprenorphine caused only hypoxemia.

View all citing articles on Scopus

View full text

Autoradiographic distribution of μ, δ and κ opioid binding sites in the superficial dorsal horn, over the rostrocaudal axis of the rat spinal cord

Abstract

Brain Research

Brain Research

Life Sci.

Brain Research

Neuropeptides

Neuropeptides

Brain Research

Brain Research

Neuropeptides